The selection of high-producing cell lines using flow cytometry and cell sorting

Expert Opinion on Biological Therapy

Volumn 4, Issue 11, 2004, Pages 1821-1829

  Carroll, Silvia ^b   Al Rubeai, Mohamed ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b NONE

Author keywords

Biopharmaceuticals; Cell culture; Flow cytometry; Gel microdrop; High producers; Matrix based secretion assays

Indexed keywords

AVIDIN; BIOTIN; GELATIN;

CELL CULTURE; CELL ENCAPSULATION; CELL ISOLATION; CELL LINE; CELL SELECTION; FLOW CYTOMETRY; GEL MICRODROP TECHNOLOGY; GENE VECTOR; GENETIC TRANSFECTION; MATRIX BASED SECRETION ASSAY; MEDICAL TECHNOLOGY; MOLECULAR CLONING; PHARMACEUTICS; RECOMBINANT GENE; REVIEW;

ANIMALS; ANTIGEN-ANTIBODY REACTIONS; AVIDIN; BIOTINYLATION; CELL CULTURE TECHNIQUES; CELL LINE; CELL SEPARATION; CHO CELLS; CRICETINAE; DRUG COMPOUNDING; FLOW CYTOMETRY; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; GELATIN; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HUMANS; HYBRIDOMAS; RECOMBINANT FUSION PROTEINS; TRANSFECTION;

EID: 8744248873     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.4.11.1821     Document Type: Review

References (74)

1. KOHLER G, MILSTEIN C: Continuous culture of fused cells secreting antibody of predefined specificity. Nature (1975) 256:495-497.
2. WIRTH M, REHM H, REED G, PUHLER A, STADLER P: Genetic engineering of animal cells. In: Biotechnology Volume 2: Genetic Engineering and Genetic Fundamentals. Puhler A (Ed.), Wiley-VCH (1993):63-744. Review of screening methods available for the selection of high-producing clones.
3. KIM NS, KIM SJ, LEE GM: Clonal variability within dihydrofloate reductase-mediated gene amplified Chinese hamster ovary cells: Stability in the absence of selective pressure. Biotechnol. Bioeng. (1998) 60:679-688.
4. BARNES LM, BENTLEY C, DICKSON AJ: Characterisation of the stability of recombinant protein production in the GS-NSO expression system. Biotechnol. Bioeng. (2001) 73(4):26l-270. Reported instability in a recombinant glutamine synthetase-NS0 cell line after 30 days of culturing.
5. KAUFMAN R, SHARP PA: Amplification and expression of sequences cotransfected with modular dihydrofolate reductase DNA gene. J. Mol. Biol. (1982) 159:601-621.
6. BEBBINGTON CR, RENNER G, THOMSON S, KING D, ABRAMS D, YARRANTON GT: High-level expression of a recombinant antibody from myeloma cells using a glutamine synthetase gene as an amplifiable selectable marker. Biotechnology (NY) (1992) 10:169-175. Introduced glutamine synthetase-selectable marker into a myeloma and amplified the vector using methionine sulfoximine (MSX).
7. GU MB, KERN JA, TODD P, KOMPALA S: Effect of amplification of dhfr and lac Z genes on growth and β-galactosidase expression in suspension cultures of recombinant CHO cell. Cytotechnology (1992) 9:237-245.
8. PENDSE GJ, KARKARES S, BAILEY JE: Effect of cloned gene dosage on cell-growth and hepatitis-B surface-antigen synthesis and secretion in recombinant CHO cells. Biotechnol. Bioeng. (1992) 40(1):119-129.
9. KROMENAKER SJ, SRIENC F: Stability of producer hybridoma cell lines after cell sorting: a case study. Biotechnol. Prog. (1994) 10:299-307.
10. KIM SJ, KIM NS, RYU CJ, HONG HJ, LEE GM: Characterisation of chimeric producing CHO cells in the course of dihydrofolate reductase-mediated gene amplification and their stability in the absence of selective pressure. Biotechnol. Bioeng. (1998) 58:73-84. Examined the stability of recombinant CHO cells during gene amplification using MSX.
11. FRAME KK, HU W-S: The loss of antibody productivity in continuous culture of hybridoma cells. Biotechnol. Bioeng. (1990) 35:469-476.
12. BORTH N, ZEYDA M, KATINGER H: Efficient selection of high-producing subclones during gene amplification of recombinant Chinese hamster ovary cells by flow cytometry and cell sorting. Biotechnol. Bioeng. (2001) 71(4):266-273. Selected high-producing recombinant CHO cells using a biotin/avidin affinity matrix. The specific antibody production rate of the clone selected using this technique was five times higher than that of the clone obtained using limiting dilution cloning.
13. CUNNINGHAM R: Overview of fluorescent probes for cytometry. In: Methods in Molecular Biology, Vol. 115: Immunocytochemical Methods and Protocols. Javois LC (Ed), Humana Press, Inc., Totowa, NJ, USA (1999):249-259.
14. RADCLIFF G, JAROSZESKI MJ: Basics of flow cytometry. In: Methods in Molecular Biology, Vol. 91: Flow Cytometry Protocols. Jaroszeski MJ, Heller R (Eds), Humana Press Inc., New Jersey, USA (1988):1-24.
15. DEAN PN: Helpful hints in flow cytometry and sorting. Cytometry (1985) 6:62-64.
16. BATTTYYE FL, LIGHT A, TARLINGTON DM: Single cell sorting and cloning. J. Immunol. Methods (2000) 243:25-32.
17. PARKS DR, BRYAN VM, OI VT, HERZENBERG LA: Antigen-specific identification and cloning of hybridomas with a fluorescence-activated cell sorter. Proc. Natl. Acad. Sci. USA (1979) 76:1962-1966. Describes labelling of hybridomas with fluorescent microspheres coupled with antigens, and cloning of these using a fluorescence-activated cell sorter.
18. DANGL J, HERZENBERG L: Selection of hybridomas and hybridoma variants using the fluorescence activated cell sorter. J. Immunol. Methods (1982) 52:1-14.
19. MARTEL F, BAZIN R, VERETTE S, LEMIEUX R: Characterisation of higher avidity monoclonal antibodies produced by murine B-cell hybridoma variants selected for increased antigen binding of membrane IgG. J. Immunol. (1988) 141:1624-1629.
20. JANTSCHEFF P, WINKLER L, KARAWAJEW L, KAISER G, BOTTEGER V, MICHEEL B: Hybrid hybridomas producing bispecific antibodies to CEA and peroxidase by a combination of HAT medium selection and fluorescence activated cell sorting. J. Immunol. Methods (1993) 163:91-97.
21. KAVATHAS P, HERZENBERG LA: Amplification of a gene coding for human T-cell differentiation antigen. Nature (1983) 306:385-387.
22. BECKERS T, HAUSER H, HUSKEN D, ENGELS JW: Expression and characterisation of a des-methionine mutant interleukin receptor (tac protein) with interleukin-2 binding affinity. J. Biol. Chem. (1988) 263:8359-8365.
23. STRAIR RK, TOWLE MJ, SMITH BR: Recombinant retroviruses encoding cell surface antigens as selectable markers. J. Virol. (1998) 62:4765-4759.
24. JOHNSTON RN, BEVERLY SM, SCHINKE RT: Rapid spontaneous dihydrofolate reductase gene amplification shown by fluorescence activated cell sorting. Proc. Natl. Acad. Sci. USA (1983) 80:3711-3715.
25. KAUFFMAN RJ, MURTHA P: Translational control mediated by eukaryotic initiation factor-2 is restricted to specific mRNAs in transfected cells. Mol. Cell. Biol. (1987) 2:1568-1571.
26. HEATH C, DILWITH R, BELFORT G: Methods for increasing antibody production in suspension and entrapped cell culture: Biochemical and flow cytometric analysis as a function of medium serum content. J. Biotechnol. (1990) 15:71-90.
27. COUTURE ML, HEATH CA: Relationship between the loss of heavy chains and the appearance of nonproducing hybridomas. Biotechnol. Bioeng. (1995) 47:270-275.
28. BORTH N, STRUTZENBERGER K, DONALIES U, KUNERT R, KATINGER H: Comparison of the production of a human monoclonal antibody against HIV-1 by heterohybridoma cells and recombinant CHO cells: A flow cytometric study. Cytotechnology (1996) 22:129-138.
29. STRUTZENBERGER K, BORTH N, KUNERT R, STEINFELLNER W, KATINGER H: Changes during subclone development and ageing of human antibody-producing recombinant CHO cells. J. Biotechnol. (1999) 69:215-226. Reported on gene copy number and site of chromosomal integration of heavy and light chain antibody-producing genes in a recombinant CHO cell.
30. MARDER P, MACIACK RS, FOUTS RL, BAKER RS, STARLING JJ: Selective cloning of hybridoma cells for enhanced immunoglobulin production using flow cytometric cell sorting and automated laser nephelometry. Cytometry (1990) 11(4):498-505.
31. SEN S, HU WS, SRIENC F: Flow cytometric study of hybridoma cell culture: correlation between cell surface fluorescence and IgG production rate. Enzyme Microb. Technol. (1990) 12:571-576.
32. MCKINNEY KL, DILWITH R, BELFORT G: Manipulation of heterogeneous hybridoma cultures for overproduction of monoclonal-antibodies. Biotechnol. Prog. (1991) 7(5):445-454. Sorted high-producing hybridoma clones using cell surface fluorescence and cell sorting. Found a positive correlation between cell surface fluorescence and specific antibody secretion.
33. CHERLET M, KROMENAKER SJ, SRIENC F: Surface IgG content of murine hybridomas-direct evidence for a variation of antibody secretion rates during the cell cycle. Biotechnol. Bioeng. (1995) 47(5):535-540.
34. WEAVER JC, WILLIAMS GB, KILBANOV A, DEMAIN AL: Gel Microdroplets: a rapid detection and enumeration of individual microorganisms by their metabolic activity. Biotechnology (NY) (1988) 6:1084-1089.
35. POWELL KT, WEAVER JC: Gel microdroplets and flow cytometry: rapid determination of antibody secretion by individual cells within a cell population. Biotechnology (NY) (1990) 8:333-337. First report of GMD secretion assay to select hybridoma cells.
36. NIR R, YISRAELI Y, LAMED R, SAHAR E: Sorting of viable bacteria and yeasts according to beta-galactosidase activity. Appl. Environ. Microbiol. (1990) 56(12):3861-3866.
37. WEAVER JC, BLISS JC, HARRISON GI, POWELL KT, WILLIAMS GB: Microdrop technology: a general method for separating cells by function and composition. Methods (1991) 2(93):234-247.
38. GOGUEN B, KERDESHA N: Clonogenic cytotoxicity testing by microdop encapsulation. Nature (1993) 363:189-190.
39. RYAN C, NGUYEN B-T, SULLIVAN S: Rapid assay for mycobacterial growth and antibiotic susceptibility using gel microdrop encapsulation. J. Clin. Microbiol. (1995) 33(7): 1720-1726.
40. GRAY F, KENNEY JS, DUNNE JF: Secretion capture and report web: use of affinity derivatized agarose microdroplets for the selection of hybridoma cells. J. Immunol. Methods (1995) 182:155-163.
41. WEAVER JC, MCGRATH P, ADAMS S: Gel Microdrop technology for rapid isolation of rare and high producing cells. Nature (1997) 3(5):583-585.
42. HAMMILL L, WELLES J, CARSON GR: The gel microdrop secretion assay: Identification of a low productivity subpopulation arising during the production of human antibody in CHO cells. Cytotechnology (2000) 34:27-37. Used GMD secretion assay to examine low- and non-producing hybridomas.
43. AKSELBAND Y, MOEN PT JR, MCGRATH P: Isolation of rare isotype switch variants in hybridoma cell lines using an agarose gel microdrop-based protein secretion assay. Assay Drug Dev. Technol. (2003) 1(5):619-626.
44. MANZ R, ASSENMACHER M, PFLUGER E, MILTENY S, RADBRUCH A: Analysis and sorting of live cells according to secreted molecules, relocated to a cell-surface affinity matrix. Proc. Natl. Acad. Sci. USA (1995) 92:1921-1925. Developed an affinity matrix to sort live cells according to their secreted molecules. Sorted hybridomas based on their antibody, and activated T lymphocytes based on their secreted cytokines.
45. FRYKMAN S, SRIENC F: Quantitating secretion rates of individual cells: design of secretion assays. Biotechnol. Bioeng. (1998) 59(2):214-226.
46. HOLMES P, AL-RUBEAI M: Improved cell line development by a high throughput affinity capture surface display technique to select for high secretors. J. Immunol. Methods (1999) 230:141-147. Selected high-producing NS0 6A1 using ACSD and cell size. Increased productivity by 30%.
47. TURCANU V, WILLIAMS NA: Cell identification and isolation on the basis of cytokine secretion: a novel tool for investigating immune responses. Nat. Med. (2001) 7(3):373-376.
48. CARROLL S: The selection and monitoring of high producing recombinant cell lines using flow cytometry. PhD thesis. The University of Birmingham (2004).
49. KENNEY J, GRAY F, ANCEL MH, DUNNE J: Production of monoclonal antibodies using a secretion capture report web. Biotechnology (NY) (1995) 13:787-790.
50. OHNO K, LEVIN B, MERUELO D: Cell-specific multidrug delivery system using streptavidin-protein A fusion protein. Biochem. Mol. Med. (1996) 58:227-233.
51. ARIENNE KJ, OKER-BLOM C, MARJOMAKI VS, BAYER ES, WILCHECK M, KULOMAA MS: Production of biologically active recombinant avidin in baculovirus-infected insect cells. Protein Expr. Purif. (1997) 9:100-108.
52. SMITH JS, KELLER JR, LOHREY NC et al.: Redirected infection of directly biotinylated recombinant adenovirus vectors through cell surface receptors and antigens. Proc. Natl. Acad. Sci. USA (1999) 96:8855-8860.
53. GREEN NM: Avidin and streptavidin. Methods Enzymol. (1990) 184:51-67.
54. WILCHEK M, BAYER EA: Introduction to avidin-biorin technology. Methods Enzymol. (1990) 184:5-13.
55. ROSANO C, AROSIO P, BOLOGNESI M: The X-ray three dimensional structure of avidin. Biomol. Eng. (1990) 16:5-13.
56. CHOW AA, MOSER CA, SPEAKER TJ, OFFIT PA: Determination of efficiency of attachment of biotinylated antibodies to avidin-linked, aqueous-based microcapsules by flow cytometry. J. Immunol. Methods (2003) 277(1-2):135-139.
57. THIERRY AC, PERRENOUD D, PINAUD S et al.: Biotinylated synthetic chemokines: their use for the development of nonradioactive whole-cell binding assays. J. Biomol. Screen. (2003) 8(3):316-326.
58. SHIMIZU T, KOZONO Y, KOZONO H, ODA M, AZUMA T: Affinity maturation of secreted IgM pentamers on B cells. Int. Immunol. (2004) 16(5):675-684.
59. STEHLIK C, KROISMAYR R, DORFLEUTNER A, BINDER BR, LIPP J: VIGR- a novel inducible adhesion family G-protein coupled receptor in endothelial cells. FEBS Lett. (2004) 569(1-3):149-155. Used cell surface biotinylation to identify VIGR.
60. ASSENMACHER M, LOHNING M, SCHEFFOLD A et al.: Commitment of individual Th1-like lymphocytes to expression of IFN-gamma versus IL-4 and IL-10: selective induction of IL-10 by sequential stimulation of naive Th cells with IL-12 and IL-4. J. Immunol. Methods (1998) 161(6):2825-2832.
61. BROSTERHUS H, BRINGS S, LEYENDECKERS H et al.: Enrichment and detection of live antigen-specific CD4+ and CD8+ T cells based on cytokine secretion. Eur. J. Immunol. (1999) 29:4053-4059.
62. SCHEFFOLD A, ASSENMACHER M, REINERS-SCHRAMM L, LAUSTER R, RADBRUCH A: High-sensitivity immunofluorescence for detection of the pro- and anti-inflammatory cytokines gamma interferon and interleukin-10 on the surface of cytokine-secreting cells. Nat. Med. (2000) 6(1): 107-110.
63. ALON R, BAYER EA, WILCHEK M: Streptavidin contains an RYD sequence which mimics the RGD receptor domain of fibronectin. Biochem. Biophys. Res. Commun. (1990) 170:1236-1241.
64. CHALFIE M, TU Y, EUSKIRCHEN G et al.: Green fluorescent protein as a marker for gene expression. Science (1994) 263:802-805.
65. MOSSER DD, CARON AW, BOURGET L et al.: Use of a dicistronic expression cassette encoding the green fluorescent protein for the screening and selection of cells expressing inducible gene products. Biotechniques (1997) 22:150-154.
66. MENG YG, LIANG J, WONG WL, CHISHOLM V: Green fluorescent protein as a second selectable marker for selection of high producing clones from transfected CHO cells. Gene (2002) 242:201-207.
67. SUBRAMIAN S, SRIENC F: Quantitative analysis of transient gene expression in mammalian cells using the green fluorescent protein. J. Biotechnol. (1996)49:137-151.
68. ZEYDA M, BORTH N, KUNERT R et al.: Optimization of sorting conditions for the selection of stable, high-producing mammalian cell lines. Biotechnol. Prog. (1999) 15:953-957.
69. CRONAN JE JR: Biotinylation of proteins in vivo. A post-translational modification to label, purify and study proteins. J. Biol. Chem. (1990) 265:10327-1033. Demonstrated site-specific biotinylation of the protein of interest.
70. REED KE, CRONANJE JR: Escherichia coli exports previously folded and biotinylated protein domains. J. Biol. Chem. (1991) 266:11425-11428.
71. PARROTT MB, BARRY MA: Metabolic biotinylation of recombinant in mammalian cells and in mice. Mol. Ther. (2000) 1:96-104.
72. CHEN G, STAHL N, YANCOPOULOS G, FANDL JP: Efficient isolation of production cell lines based on secretion levels. Cell Culture Engineering IX Conference. Cancun, Mexico (7-12 March 2004).
73. HOLASH J, DAVIS S, PAPADOPOULOS N et al.: VEGF-Trap: a VEGF blocker with potent antitumor effects. Proc. Natl. Acad. Sci. USA (2002) 99:11393-11398.
74. ECONOMIDES AN, CAROENTER LR, RUDGE JS et al.: Cytokine traps: multicomponent, high-affinity blockers of cytokine action. Nat. Med. (2003) 9(1):47-52.